COMBINATION OF RECEPTOR ACTIVATOR ACTIVATED BY FENOFIBRATE PEROXISOME-PROLIFERATOR (PPAR) WITH STEROL ABSORPTION INHIBITOR EZETIMIBE FOR VASCULAR INDICATIONS

摘要

Invention herewith described refers to the combination of receptor activator activated by fenofibrate peroxisome-proliferator (PPAR) with sterol absorption inhibitor ezetimibe for vascular indications. It describes the preparations, therapeutic combinations and procedures that include: a) at least one receptor activated by peroxisome proliferator and b) at least one substituted azetidinone or substituted -lactam sterol absorption inhibitor which can be used to treat vascular diseases, diabetes, obesity and sterol-lowering in plasma.